Pub Date : 2025-01-23eCollection Date: 2024-01-01DOI: 10.3389/frsle.2024.1496923
Mathias Sarkez-Knudsen, Martin Ballegaard, Henning Piilgaard, Esben Ahrens, Martin Christian Hemmsen, Tobias Søren Andersen, Jakob Eyvind Bradram, Preben Homøe
Introduction: Excessive daytime sleepiness (EDS) is a key symptom for patients with obstructive sleep apnea (OSA). Despite important limitations in the longitudinal monitoring of EDS, the Epworth Sleepiness Scale (ESS), the Maintenance of Wakefulness Test, and the Multiple Sleep Latency Test (MSLT) are the best available objective tests to predict EDS. Limited information exists on the day-to-day fluctuations of sleepiness symptoms from the everyday life perspective of OSA patients. The most feared is sudden sleep episodes that cause traffic accidents. The following study protocol investigates the novel possibilities of ultra-long-term Electroencephalography (EEG) (ULT-EEG) home monitoring in sleepy OSA patients with a subcutaneous implant. We hypothesize that the high-frequency testing from ULT-EEG, in combination with an ecological momentary assessment (EMA), can provide the information to develop new electrophysiological monitoring of sleep propensity as an alternative to the well-established, yet subjective, ESS.
Methods: This clinical exploratory and experimental study will include 15 treatment-naïve patients with severe OSA, with a baseline ESS score above 10. The subjects will be implanted with a two-channel subcutaneous EEG monitoring device upon inclusion and a confirmative polysomnography MSLT. Subcutaneous EEG is recorded 24/7 for 6 weeks before and 6 weeks during continuous positive airway pressure (CPAP) treatment. Daily assessments with the Karolinska Sleepiness Scale, the Psychomotor Vigilance Task test, and a sleep/nap diary will be collected using EMA methods.
Discussion: This study combines data collection from sleepy OSA patients' natural environments using ULT-EEG and EMA methods to obtain sleepiness metrics suitable for developing and preliminarily validating the possibilities of ULT-EEG sleepiness monitoring. We aim to prove a new concept of monitoring sleepiness symptoms in OSA patients and gain new insights into CPAP-related sleepiness rehabilitation.
Ethics and dissemination: All participants will provide written informed consent to participate in this study. Ethical approval from the Region Zealand Ethics Committee on 13/09/2021 (SJ939, EMN-2021-06803). The study will be conducted in accordance with local legislation and institutional requirements and comply with the Declaration of Helsinki and the General Data Protection Regulation (GDPR).
{"title":"Exploring SLEEPINESS through home monitoring with ultra-long-term subcutaneous EEG and ecological momentary assessment in sleepy treatment naïve obstructive sleep apnea patients starting CPAP treatment-A study protocol article.","authors":"Mathias Sarkez-Knudsen, Martin Ballegaard, Henning Piilgaard, Esben Ahrens, Martin Christian Hemmsen, Tobias Søren Andersen, Jakob Eyvind Bradram, Preben Homøe","doi":"10.3389/frsle.2024.1496923","DOIUrl":"10.3389/frsle.2024.1496923","url":null,"abstract":"<p><strong>Introduction: </strong>Excessive daytime sleepiness (EDS) is a key symptom for patients with obstructive sleep apnea (OSA). Despite important limitations in the longitudinal monitoring of EDS, the Epworth Sleepiness Scale (ESS), the Maintenance of Wakefulness Test, and the Multiple Sleep Latency Test (MSLT) are the best available objective tests to predict EDS. Limited information exists on the day-to-day fluctuations of sleepiness symptoms from the everyday life perspective of OSA patients. The most feared is sudden sleep episodes that cause traffic accidents. The following study protocol investigates the novel possibilities of ultra-long-term Electroencephalography (EEG) (ULT-EEG) home monitoring in sleepy OSA patients with a subcutaneous implant. We hypothesize that the high-frequency testing from ULT-EEG, in combination with an ecological momentary assessment (EMA), can provide the information to develop new electrophysiological monitoring of sleep propensity as an alternative to the well-established, yet subjective, ESS.</p><p><strong>Methods: </strong>This clinical exploratory and experimental study will include 15 treatment-naïve patients with severe OSA, with a baseline ESS score above 10. The subjects will be implanted with a two-channel subcutaneous EEG monitoring device upon inclusion and a confirmative polysomnography MSLT. Subcutaneous EEG is recorded 24/7 for 6 weeks before and 6 weeks during continuous positive airway pressure (CPAP) treatment. Daily assessments with the Karolinska Sleepiness Scale, the Psychomotor Vigilance Task test, and a sleep/nap diary will be collected using EMA methods.</p><p><strong>Discussion: </strong>This study combines data collection from sleepy OSA patients' natural environments using ULT-EEG and EMA methods to obtain sleepiness metrics suitable for developing and preliminarily validating the possibilities of ULT-EEG sleepiness monitoring. We aim to prove a new concept of monitoring sleepiness symptoms in OSA patients and gain new insights into CPAP-related sleepiness rehabilitation.</p><p><strong>Ethics and dissemination: </strong>All participants will provide written informed consent to participate in this study. Ethical approval from the Region Zealand Ethics Committee on 13/09/2021 (SJ939, EMN-2021-06803). The study will be conducted in accordance with local legislation and institutional requirements and comply with the Declaration of Helsinki and the General Data Protection Regulation (GDPR).</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"3 ","pages":"1496923"},"PeriodicalIF":0.0,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Sleep apnea can have severe negative health effects, including cardiovascular diseases, metabolic disorders, and decreased quality of life. Continuous positive airway pressure (CPAP) therapy is highly effective and the gold standard treatment for sleep apnea; however, traditionally fragmented sleep healthcare has resulted in low levels of treatment adoption and adherence. A recent white paper analysis of traditional health plan claims found that a comprehensive model significantly outperformed traditional health plans with higher rates of adoption (80 vs. 49%), adherence (62 vs. 25%), and persistence (53 vs. 11%) to CPAP therapy, which resulted in lower total healthcare costs. To understand the patient experience in these models of care, this study compared patient satisfaction between the traditional sleep care approach and a clinically integrated, comprehensive sleep care program.
Methods: A survey was developed to understand differences in the patient experience with the two different care models with respect to: access to sleep care, including time from initial appointment to seeing a sleep specialist, referral and insurance process; ease of sleep testing process and receiving a diagnosis; adoption, quality of education, and training with CPAP; ongoing adherence support with CPAP, and quality of life. Data were compared using descriptive statistics and Chi-square analyses.
Results: A significantly higher proportion of patients in the comprehensive model were satisfied with all measured points in the patient's journey. Notably, twice as many patients in the comprehensive model were very satisfied with: ease of navigating the testing process, time between diagnosis and CPAP adoption, insurance navigation for CPAP approval, and availability and level of ongoing CPAP support. Comprehensive care patients experienced fewer work disruptions due to sleep apnea: only 7% missed work in the past 3 months, compared to 58% in the traditional model.
Discussion: Overall, the study highlights the benefits of a comprehensive care model in improving patient satisfaction with their sleep apnea journey and overall quality of life for individuals with sleep apnea. Pairing this positive patient experience data with prior data from the same treatment model shows that removing obstacles within a patient's journey positively impacts satisfaction while simultaneously improving adherence rates and reducing total healthcare costs.
{"title":"Patient satisfaction with a clinically integrated sleep apnea care model vs. the current sleep care paradigm.","authors":"Gregory D Salinas, Wendy Cerenzia, Brandon Coleman, Frances Thorndike, Samantha Edington, Heidi Riney","doi":"10.3389/frsle.2024.1534441","DOIUrl":"10.3389/frsle.2024.1534441","url":null,"abstract":"<p><strong>Introduction: </strong>Sleep apnea can have severe negative health effects, including cardiovascular diseases, metabolic disorders, and decreased quality of life. Continuous positive airway pressure (CPAP) therapy is highly effective and the gold standard treatment for sleep apnea; however, traditionally fragmented sleep healthcare has resulted in low levels of treatment adoption and adherence. A recent white paper analysis of traditional health plan claims found that a comprehensive model significantly outperformed traditional health plans with higher rates of adoption (80 vs. 49%), adherence (62 vs. 25%), and persistence (53 vs. 11%) to CPAP therapy, which resulted in lower total healthcare costs. To understand the patient experience in these models of care, this study compared patient satisfaction between the traditional sleep care approach and a clinically integrated, comprehensive sleep care program.</p><p><strong>Methods: </strong>A survey was developed to understand differences in the patient experience with the two different care models with respect to: access to sleep care, including time from initial appointment to seeing a sleep specialist, referral and insurance process; ease of sleep testing process and receiving a diagnosis; adoption, quality of education, and training with CPAP; ongoing adherence support with CPAP, and quality of life. Data were compared using descriptive statistics and Chi-square analyses.</p><p><strong>Results: </strong>A significantly higher proportion of patients in the comprehensive model were satisfied with all measured points in the patient's journey. Notably, twice as many patients in the comprehensive model were very satisfied with: ease of navigating the testing process, time between diagnosis and CPAP adoption, insurance navigation for CPAP approval, and availability and level of ongoing CPAP support. Comprehensive care patients experienced fewer work disruptions due to sleep apnea: only 7% missed work in the past 3 months, compared to 58% in the traditional model.</p><p><strong>Discussion: </strong>Overall, the study highlights the benefits of a comprehensive care model in improving patient satisfaction with their sleep apnea journey and overall quality of life for individuals with sleep apnea. Pairing this positive patient experience data with prior data from the same treatment model shows that removing obstacles within a patient's journey positively impacts satisfaction while simultaneously improving adherence rates and reducing total healthcare costs.</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"3 ","pages":"1534441"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-08eCollection Date: 2024-01-01DOI: 10.3389/frsle.2024.1524593
Michelle Wei, Jennifer A Teske, Saif Mashaqi, Daniel Combs
Obstructive sleep apnea (OSA) is a common sleep disorder associated with serious neurological and cardiovascular complications. Intermittent hypoxia and reoxygenation, a key feature of OSA, produces molecular signals that activate various inflammatory pathways, notably the inflammasome-a multiprotein complex that promotes the release of pro-inflammatory cytokines including IL-18 and IL-1β. This results in systemic inflammation, which contributes to the development of the neurological and cardiovascular complications seen in OSA. In this review, we will first examine the pathways through which intermittent hypoxia induces inflammasome activation. Then, we will connect the inflammasome to the downstream neurological and cardiovascular effects of OSA. Finally, we will explore potential interactions between the inflammasome and OSA treatments including Continuous Positive Airway Pressure therapy and glucagon like peptide-1 receptor agonists (GLP-1RAs).
{"title":"Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies.","authors":"Michelle Wei, Jennifer A Teske, Saif Mashaqi, Daniel Combs","doi":"10.3389/frsle.2024.1524593","DOIUrl":"10.3389/frsle.2024.1524593","url":null,"abstract":"<p><p>Obstructive sleep apnea (OSA) is a common sleep disorder associated with serious neurological and cardiovascular complications. Intermittent hypoxia and reoxygenation, a key feature of OSA, produces molecular signals that activate various inflammatory pathways, notably the inflammasome-a multiprotein complex that promotes the release of pro-inflammatory cytokines including IL-18 and IL-1β. This results in systemic inflammation, which contributes to the development of the neurological and cardiovascular complications seen in OSA. In this review, we will first examine the pathways through which intermittent hypoxia induces inflammasome activation. Then, we will connect the inflammasome to the downstream neurological and cardiovascular effects of OSA. Finally, we will explore potential interactions between the inflammasome and OSA treatments including Continuous Positive Airway Pressure therapy and glucagon like peptide-1 receptor agonists (GLP-1RAs).</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"3 ","pages":"1524593"},"PeriodicalIF":0.0,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713997/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-07-10DOI: 10.3389/frsle.2025.1593196
Nicole Tacugue, Jessica J Love, Jakob M Cherry, Jacqueline Lane, Joe Kossowsky
Introduction: Sleep dysregulation is highly prevalent in pediatric chronic pain conditions and associated with poorer clinical outcomes. Interactions between underlying circadian misalignments and pain in pediatric populations remain unclear. Dim-light melatonin onset collections conducted in external lab settings are standard for measuring circadian rhythmicity by examining fluctuations in melatonin levels. However, present limitations prevent us from capturing a typical night's sleep and minimize accessibility to broader populations due to geographic, financial, and temporal barriers. We investigated a novel approach in which participants complete collections in an entirely self-directed manner using an at-home diagnostic kit.
Methods: Participants included pediatric patients with diagnosed chronic pain and healthy controls. The 3-week protocol involved sleep, activity, and light tracking, self-reported sleep diaries, a survey determining morningness-eveningness chronotypes, one self-directed home dim-light melatonin onset collection with objective compliance measures, and assessment of study protocol acceptability.
Results and discussion: In a sample of pediatric patients with diagnosed chronic pain (N = 6, Mage =14.5, SD = 2.74, 66.7% female) and a subset of healthy controls (N = 6, Mage =13.3, SD=2.73, 50% female), both the Hockeystick method and 3 pg/ml dim-light melatonin onset threshold were employed to calculate salivary dim-light melatonin onset times in 8 of the 12 participants. On average, dim-light melatonin onset times were 1 h and 43 min earlier than self-reported sleep onset times. Our results illustrate the feasibility and accuracy of self-directed, remote dim-light melatonin onset collections in pediatric populations. With supplementary research validating this optimized approach to measure endogenous circadian phase, more specific aspects of sleep can be targeted in pain intervention strategies to further optimize clinical outcomes in a greater population of pediatric patients.
{"title":"Feasibility and acceptability of self-directed, remote dim-light melatonin onset collection in pediatric patients diagnosed with chronic pain.","authors":"Nicole Tacugue, Jessica J Love, Jakob M Cherry, Jacqueline Lane, Joe Kossowsky","doi":"10.3389/frsle.2025.1593196","DOIUrl":"10.3389/frsle.2025.1593196","url":null,"abstract":"<p><strong>Introduction: </strong>Sleep dysregulation is highly prevalent in pediatric chronic pain conditions and associated with poorer clinical outcomes. Interactions between underlying circadian misalignments and pain in pediatric populations remain unclear. Dim-light melatonin onset collections conducted in external lab settings are standard for measuring circadian rhythmicity by examining fluctuations in melatonin levels. However, present limitations prevent us from capturing a typical night's sleep and minimize accessibility to broader populations due to geographic, financial, and temporal barriers. We investigated a novel approach in which participants complete collections in an entirely self-directed manner using an at-home diagnostic kit.</p><p><strong>Methods: </strong>Participants included pediatric patients with diagnosed chronic pain and healthy controls. The 3-week protocol involved sleep, activity, and light tracking, self-reported sleep diaries, a survey determining morningness-eveningness chronotypes, one self-directed home dim-light melatonin onset collection with objective compliance measures, and assessment of study protocol acceptability.</p><p><strong>Results and discussion: </strong>In a sample of pediatric patients with diagnosed chronic pain (<i>N</i> = 6, M<sub>age</sub> =14.5, SD = 2.74, 66.7% female) and a subset of healthy controls (<i>N</i> = 6, M<sub>age</sub> =13.3, SD=2.73, 50% female), both the Hockeystick method and 3 pg/ml dim-light melatonin onset threshold were employed to calculate salivary dim-light melatonin onset times in 8 of the 12 participants. On average, dim-light melatonin onset times were 1 h and 43 min earlier than self-reported sleep onset times. Our results illustrate the feasibility and accuracy of self-directed, remote dim-light melatonin onset collections in pediatric populations. With supplementary research validating this optimized approach to measure endogenous circadian phase, more specific aspects of sleep can be targeted in pain intervention strategies to further optimize clinical outcomes in a greater population of pediatric patients.</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"4 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12435390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-09-03DOI: 10.3389/frsle.2025.1683978
Darlynn M Rojo-Wissar, Jessica M Meers, Patricia L Haynes
{"title":"Editorial: Women in Insomnia.","authors":"Darlynn M Rojo-Wissar, Jessica M Meers, Patricia L Haynes","doi":"10.3389/frsle.2025.1683978","DOIUrl":"10.3389/frsle.2025.1683978","url":null,"abstract":"","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"4 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12435535/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145076746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-03-06DOI: 10.3389/frsle.2025.1516094
Katherine Domar Ostrow, Olivia Rieur, Robert W Moeller, Martin Seehuus
Loneliness and insomnia are endemic in college students, and emotion regulation is strongly related to both. Starting with a biopsychosocial framework, the present study tested a model in which emotional repair mediated the relationship between loneliness and insomnia, with the goal of using a potential mechanism of action to address loneliness. Participants were undergraduate students (N=1,513) in the United States who completed a survey including the Trait Meta-Mood Scale, Sleep Condition Indicator, and UCLA Loneliness Scale, amongst other measures. Insomnia had a significant total negative effect on loneliness, B = -0.46, 95% CI [-0.54, -0.39]. Emotional repair partially mediated this relationship, with an indirect effect of B = 0.015, 95% CI [-0.19, -0.12]. Participants with better sleep were more able to regulate their emotions, and thus tended to experience lower levels of loneliness. Treating insomnia (e.g., CBT-I) or skills associated with emotional repair and regulation (e.g., transdiagnostic approaches to emotion regulation) could reduce overall loneliness.
{"title":"From sleeplessness to solitude: emotional repair as a buffer between insomnia and loneliness in university students.","authors":"Katherine Domar Ostrow, Olivia Rieur, Robert W Moeller, Martin Seehuus","doi":"10.3389/frsle.2025.1516094","DOIUrl":"10.3389/frsle.2025.1516094","url":null,"abstract":"<p><p>Loneliness and insomnia are endemic in college students, and emotion regulation is strongly related to both. Starting with a biopsychosocial framework, the present study tested a model in which emotional repair mediated the relationship between loneliness and insomnia, with the goal of using a potential mechanism of action to address loneliness. Participants were undergraduate students (N=1,513) in the United States who completed a survey including the Trait Meta-Mood Scale, Sleep Condition Indicator, and UCLA Loneliness Scale, amongst other measures. Insomnia had a significant total negative effect on loneliness, B = -0.46, 95% CI [-0.54, -0.39]. Emotional repair partially mediated this relationship, with an indirect effect of B = 0.015, 95% CI [-0.19, -0.12]. Participants with better sleep were more able to regulate their emotions, and thus tended to experience lower levels of loneliness. Treating insomnia (e.g., CBT-I) or skills associated with emotional repair and regulation (e.g., transdiagnostic approaches to emotion regulation) could reduce overall loneliness.</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"4 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11936514/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143712432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-20eCollection Date: 2024-01-01DOI: 10.3389/frsle.2024.1522635
Ludovico Messineo, David P White, William H Noah
Despite being the gold-standard treatment for obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP) faces important challenges, particularly with patient adherence. Many individuals find CPAP difficult to tolerate due to noise, social inconveniences, characteristics inherently linked to their sleep disorder and side effects, including mask discomfort, air leaks, nasal congestion, and the unnatural sensation of exhaling against positive pressure. All this often leads to reduced usage, limiting CPAP's potential to deliver long-term health benefits. This review revisits the dynamics of pharyngeal collapse during sleep on PAP, offering a new interpretation that challenges the long-standing view that higher inspiratory pressure is required to maintain pharyngeal patency. Emerging evidence, combined with the knowledge from older studies, suggests that airway collapse often occurs near end-expiration, which may be the only time that substantial positive airway pressure is required. Efforts to improve CPAP compliance have reduced expiratory pressure, leading to the introduction of bilevel PAP (BPAP) and expiratory pressure relief algorithms, which may cause airway destabilization, without yielding the improvements in adherence that were initially anticipated. Thus, despite over three decades of innovation, which have also seen heated humidifiers and tubes, customized 3D-printed masks and auto-titrating PAP come to market, there has been limited success in systematically increasing long-term CPAP adherence rates. In response, we discuss novel approaches such as -Com® and KairosPAP™ (KPAP™), which reduce inspiratory pressure and, in the case of KPAP™, also much of expiratory pressure, returning to full pressure only at the end of expiration. Recent studies suggest these technologies improve comfort and reduce unintentional leaks and may lead to better adherence without sacrificing treatment effectiveness. This aligns with the hypothesis that stabilizing the airway during end-expiration may be key to enhancing CPAP comfort and adherence. In conclusion, while technological advancements have improved the CPAP experience, further progress will likely come from solutions that better address patient comfort with the applied pressure. KPAP™ is one such innovation with the potential to enhance adherence, but additional research is needed to fully understand its long-term impact and effectiveness in PAP therapy for OSA.
{"title":"Positive airway pressure delivery: overcoming old hurdles, exploring new frontiers.","authors":"Ludovico Messineo, David P White, William H Noah","doi":"10.3389/frsle.2024.1522635","DOIUrl":"10.3389/frsle.2024.1522635","url":null,"abstract":"<p><p>Despite being the gold-standard treatment for obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP) faces important challenges, particularly with patient adherence. Many individuals find CPAP difficult to tolerate due to noise, social inconveniences, characteristics inherently linked to their sleep disorder and side effects, including mask discomfort, air leaks, nasal congestion, and the unnatural sensation of exhaling against positive pressure. All this often leads to reduced usage, limiting CPAP's potential to deliver long-term health benefits. This review revisits the dynamics of pharyngeal collapse during sleep on PAP, offering a new interpretation that challenges the long-standing view that higher inspiratory pressure is required to maintain pharyngeal patency. Emerging evidence, combined with the knowledge from older studies, suggests that airway collapse often occurs near end-expiration, which may be the only time that substantial positive airway pressure is required. Efforts to improve CPAP compliance have reduced expiratory pressure, leading to the introduction of bilevel PAP (BPAP) and expiratory pressure relief algorithms, which may cause airway destabilization, without yielding the improvements in adherence that were initially anticipated. Thus, despite over three decades of innovation, which have also seen heated humidifiers and tubes, customized 3D-printed masks and auto-titrating PAP come to market, there has been limited success in systematically increasing long-term CPAP adherence rates. In response, we discuss novel approaches such as <math> <mover><mrow><mtext>V</mtext></mrow> <mo>.</mo></mover> </math> -Com<sup>®</sup> and KairosPAP™ (KPAP™), which reduce inspiratory pressure and, in the case of KPAP™, also much of expiratory pressure, returning to full pressure only at the end of expiration. Recent studies suggest these technologies improve comfort and reduce unintentional leaks and may lead to better adherence without sacrificing treatment effectiveness. This aligns with the hypothesis that stabilizing the airway during end-expiration may be key to enhancing CPAP comfort and adherence. In conclusion, while technological advancements have improved the CPAP experience, further progress will likely come from solutions that better address patient comfort with the applied pressure. KPAP™ is one such innovation with the potential to enhance adherence, but additional research is needed to fully understand its long-term impact and effectiveness in PAP therapy for OSA.</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"3 ","pages":"1522635"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-12-13eCollection Date: 2024-01-01DOI: 10.3389/frsle.2024.1481878
Sohrab Saeb, Benjamin W Nelson, Poulami Barman, Nishant Verma, Hannah Allen, Massimiliano de Zambotti, Fiona C Baker, Nicole Arra, Niranjan Sridhar, Shannon S Sullivan, Scooter Plowman, Erin Rainaldi, Ritu Kapur, Sooyoon Shin
Introduction: This study evaluated the performance of a wrist-worn wearable, Verily Study Watch (VSW), in detecting key sleep measures against polysomnography (PSG).
Methods: We collected data from 41 adults without obstructive sleep apnea or insomnia during a single overnight laboratory visit. We evaluated epoch-by-epoch performance for sleep vs. wake classification, sleep stage classification and duration, total sleep time (TST), wake after sleep onset (WASO), sleep onset latency (SOL), sleep efficiency (SE), and number of awakenings (NAWK). Performance metrics included sensitivity, specificity, Cohen's kappa, and Bland-Altman analyses.
Results: Sensitivity and specificity (95% CIs) of sleep vs. wake classification were 0.97 (0.96, 0.98) and 0.70 (0.66, 0.74), respectively. Cohen's kappa (95% CI) for 4-class stage detection was 0.64 (0.18, 0.82). Most VSW sleep measures had proportional bias. The mean bias values (95% CI) were 14.0 min (5.55, 23.20) for TST, -13.1 min (-21.33, -6.21) for WASO, 2.97% (1.25, 4.84) for SE, -1.34 min (-7.29, 4.81) for SOL, 1.91 min (-8.28, 11.98) for light sleep duration, 5.24 min (-3.35, 14.13) for deep sleep duration, and 6.39 min (-0.68, 13.18) for REM sleep duration. Mean and median NAWK count differences (95% CI) were 0.05 (-0.42, 0.53) and 0.0 (0.0, 0.0), respectively.
Discussion: Results support applying the VSW to track overnight sleep measures in free-living settings. Registered at clinicaltrials.gov (NCT05276362).
简介:本研究评估了腕戴式可穿戴设备Verily study Watch (VSW)在检测多导睡眠图(PSG)关键睡眠指标方面的性能。方法:我们收集了41名没有阻塞性睡眠呼吸暂停或失眠的成年人的数据。我们评估了睡眠与清醒分类、睡眠阶段分类和持续时间、总睡眠时间(TST)、睡眠后醒来(WASO)、睡眠发作潜伏期(SOL)、睡眠效率(SE)和觉醒次数(NAWK)的逐epoch表现。性能指标包括敏感性、特异性、科恩卡帕分析和布兰德-奥特曼分析。结果:睡眠与清醒分类的敏感性和特异性(95% ci)分别为0.97(0.96,0.98)和0.70(0.66,0.74)。4级分期检测的Cohen's kappa (95% CI)为0.64(0.18,0.82)。大多数VSW睡眠测量都存在比例偏差。平均偏倚值(95% CI)分别为:TST 14.0 min (5.55, 23.20), WASO -13.1 min (-21.33, -6.21), SE 2.97% (1.25, 4.84), SOL -1.34 min(-7.29, 4.81),浅睡眠时间1.91 min(-8.28, 11.98),深度睡眠时间5.24 min (-3.35, 14.13), REM睡眠时间6.39 min(-0.68, 13.18)。NAWK计数的平均值和中位数差异(95% CI)分别为0.05(-0.42,0.53)和0.0(0.0,0.0)。讨论:结果支持应用VSW来跟踪自由生活环境下的夜间睡眠测量。在clinicaltrials.gov注册(NCT05276362)。
{"title":"Performance of the Verily Study Watch for measuring sleep compared to polysomnography.","authors":"Sohrab Saeb, Benjamin W Nelson, Poulami Barman, Nishant Verma, Hannah Allen, Massimiliano de Zambotti, Fiona C Baker, Nicole Arra, Niranjan Sridhar, Shannon S Sullivan, Scooter Plowman, Erin Rainaldi, Ritu Kapur, Sooyoon Shin","doi":"10.3389/frsle.2024.1481878","DOIUrl":"10.3389/frsle.2024.1481878","url":null,"abstract":"<p><strong>Introduction: </strong>This study evaluated the performance of a wrist-worn wearable, Verily Study Watch (VSW), in detecting key sleep measures against polysomnography (PSG).</p><p><strong>Methods: </strong>We collected data from 41 adults without obstructive sleep apnea or insomnia during a single overnight laboratory visit. We evaluated epoch-by-epoch performance for sleep vs. wake classification, sleep stage classification and duration, total sleep time (TST), wake after sleep onset (WASO), sleep onset latency (SOL), sleep efficiency (SE), and number of awakenings (NAWK). Performance metrics included sensitivity, specificity, Cohen's kappa, and Bland-Altman analyses.</p><p><strong>Results: </strong>Sensitivity and specificity (95% CIs) of sleep vs. wake classification were 0.97 (0.96, 0.98) and 0.70 (0.66, 0.74), respectively. Cohen's kappa (95% CI) for 4-class stage detection was 0.64 (0.18, 0.82). Most VSW sleep measures had proportional bias. The mean bias values (95% CI) were 14.0 min (5.55, 23.20) for TST, -13.1 min (-21.33, -6.21) for WASO, 2.97% (1.25, 4.84) for SE, -1.34 min (-7.29, 4.81) for SOL, 1.91 min (-8.28, 11.98) for <i>light sleep</i> duration, 5.24 min (-3.35, 14.13) for <i>deep sleep</i> duration, and 6.39 min (-0.68, 13.18) for <i>REM sleep</i> duration. Mean and median NAWK count differences (95% CI) were 0.05 (-0.42, 0.53) and 0.0 (0.0, 0.0), respectively.</p><p><strong>Discussion: </strong>Results support applying the VSW to track overnight sleep measures in free-living settings. Registered at clinicaltrials.gov (NCT05276362).</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"3 ","pages":"1481878"},"PeriodicalIF":0.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-28eCollection Date: 2024-01-01DOI: 10.3389/frsle.2024.1459349
Deborah Olmstead, Allison Carroll, Jennifer Klein, Joanna E MacLean
Objectives: To identify factors to optimize long-term non-invasive ventilation (LT-NIV) use by exploring the experience of children using LT-NIV and their parents.
Study design and methods: A qualitative framework analysis method was used. Children aged 8-12 years who used LT-NIV for at least 3-months and their parents/guardians were approached to participate. Thematic analysis of data derived from focus group interviews, conducted separately for children and parents, was performed. Findings were coded and grouped into identified themes.
Results: Data analysis identified four themes: (1) "The double-edged sword," which identified benefits and challenges of LT-NIV use; (2) "Feeling different," where children and parents described fears, frustrations, and concerns including emotional and social implications, and physical changes; (3) "It's not just about the mask," highlighted the influence of equipment issues, including the mask interface, headgear, tubing and humidity, and their impact on tolerance and use of LT-NIV; and (4) "Through the eyes of experience-children and parents as experts for change," which captured ideas for the functional and aesthetic improvement of the equipment including the need for pediatric specific technology.
Conclusions: LT-NIV use has two sides; it helps to improve lives though requires an investment of time and commitment to ensure success. Investing in pediatric-specific equipment needs to be a priority as do alliances between healthcare providers, children who use LT-NIV, and their families. Future technology development and studies of adherence need to consider the experiences of children and their families to reduce the challenges and support optimal use of LT-NIV.
{"title":"The experience of children using long-term non-invasive ventilation: a qualitative study.","authors":"Deborah Olmstead, Allison Carroll, Jennifer Klein, Joanna E MacLean","doi":"10.3389/frsle.2024.1459349","DOIUrl":"10.3389/frsle.2024.1459349","url":null,"abstract":"<p><strong>Objectives: </strong>To identify factors to optimize long-term non-invasive ventilation (LT-NIV) use by exploring the experience of children using LT-NIV and their parents.</p><p><strong>Study design and methods: </strong>A qualitative framework analysis method was used. Children aged 8-12 years who used LT-NIV for at least 3-months and their parents/guardians were approached to participate. Thematic analysis of data derived from focus group interviews, conducted separately for children and parents, was performed. Findings were coded and grouped into identified themes.</p><p><strong>Results: </strong>Data analysis identified four themes: (1) \"The double-edged sword,\" which identified benefits and challenges of LT-NIV use; (2) \"Feeling different,\" where children and parents described fears, frustrations, and concerns including emotional and social implications, and physical changes; (3) \"It's not just about the mask,\" highlighted the influence of equipment issues, including the mask interface, headgear, tubing and humidity, and their impact on tolerance and use of LT-NIV; and (4) \"Through the eyes of experience-children and parents as experts for change,\" which captured ideas for the functional and aesthetic improvement of the equipment including the need for pediatric specific technology.</p><p><strong>Conclusions: </strong>LT-NIV use has two sides; it helps to improve lives though requires an investment of time and commitment to ensure success. Investing in pediatric-specific equipment needs to be a priority as do alliances between healthcare providers, children who use LT-NIV, and their families. Future technology development and studies of adherence need to consider the experiences of children and their families to reduce the challenges and support optimal use of LT-NIV.</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"3 ","pages":"1459349"},"PeriodicalIF":0.0,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-27eCollection Date: 2024-01-01DOI: 10.3389/frsle.2024.1477046
Astrid N Zamora, Elizabeth F S Roberts, Lilian Sharp, Catherine Borra, Jennifer Lee, Martha M Téllez-Rojo, Karen E Peterson, Libni A Torres-Olascoaga, Alejandra Cantoral, Erica C Jansen
Purpose: Little is known regarding women's lived experiences of how diet impacts sleep. Based on ethnographic interviews among working-class women from Mexico City, our primary aim was to identify themes related to diet and sleep among midlife women. Informed by qualitative analyses, a secondary aim was to examine associations between tea and sleep duration in a broader cohort.
Materials and methods: We conducted a cross-sectional study that entailed in-depth ethnographic interviews about sleep and other behaviors, including diet, with a purposive sample of 30 women from the ELEMENT cohort. Ethnographer field notes and transcripts were analyzed using thematic analysis. Guided by findings from the interviews demonstrating that tea consumption might be associated with sleep, we conducted post-hoc analyses of the relationship between tea and sleep duration using data from food frequency questionnaires and actigraphy, respectively, in the broader cohort (n = 406).
Results: The mean (SD) age of the ethnographic sample was 50.0 (9.0) years. The top noted theme was the use of herbal tea (in Spanish infusion) to improve sleep; most women (29/30) discussed herbal teas, characterizing them as a "natural remedy" to facilitate sleep. The mean (SD) age of the broader sample (N = 406) was 48.4 (6.2) years. Post-hoc analyses revealed positive associations between tea without sugar (though not necessarily herbal tea) and sleep duration. We found that every serving of tea without sugar consumed was associated with an 18.0 min per night [β (SE) = 18.0 (7.8); p = 0.022] and a 13.4 min per night [β (SE) =13.4 (5.6); p = 0.017] increase in weekend and 7-day sleep duration, respectively.
Conclusions: Within a sample of 30 midlife women, dietary practices were described in relation to sleep, specifically the consumption of herbal teas to promote sleep.
{"title":"Tea and other diet-related practices in relation to sleep health in midlife women from Mexico City: qualitative and quantitative findings.","authors":"Astrid N Zamora, Elizabeth F S Roberts, Lilian Sharp, Catherine Borra, Jennifer Lee, Martha M Téllez-Rojo, Karen E Peterson, Libni A Torres-Olascoaga, Alejandra Cantoral, Erica C Jansen","doi":"10.3389/frsle.2024.1477046","DOIUrl":"10.3389/frsle.2024.1477046","url":null,"abstract":"<p><strong>Purpose: </strong>Little is known regarding women's lived experiences of how diet impacts sleep. Based on ethnographic interviews among working-class women from Mexico City, our primary aim was to identify themes related to diet and sleep among midlife women. Informed by qualitative analyses, a secondary aim was to examine associations between tea and sleep duration in a broader cohort.</p><p><strong>Materials and methods: </strong>We conducted a cross-sectional study that entailed in-depth ethnographic interviews about sleep and other behaviors, including diet, with a purposive sample of 30 women from the ELEMENT cohort. Ethnographer field notes and transcripts were analyzed using thematic analysis. Guided by findings from the interviews demonstrating that tea consumption might be associated with sleep, we conducted <i>post-hoc</i> analyses of the relationship between tea and sleep duration using data from food frequency questionnaires and actigraphy, respectively, in the broader cohort (<i>n</i> = 406).</p><p><strong>Results: </strong>The mean (SD) age of the ethnographic sample was 50.0 (9.0) years. The top noted theme was the use of herbal tea (in Spanish <i>infusion</i>) to improve sleep; most women (29/30) discussed herbal teas, characterizing them as a \"natural remedy\" to facilitate sleep. The mean (SD) age of the broader sample (<i>N</i> = 406) was 48.4 (6.2) years. <i>Post-hoc</i> analyses revealed positive associations between tea without sugar (though not necessarily herbal tea) and sleep duration. We found that every serving of tea without sugar consumed was associated with an 18.0 min per night [β (SE) = 18.0 (7.8); <i>p</i> = 0.022] and a 13.4 min per night [β (SE) =13.4 (5.6); <i>p</i> = 0.017] increase in weekend and 7-day sleep duration, respectively.</p><p><strong>Conclusions: </strong>Within a sample of 30 midlife women, dietary practices were described in relation to sleep, specifically the consumption of herbal teas to promote sleep.</p>","PeriodicalId":73106,"journal":{"name":"Frontiers in sleep","volume":"3 ","pages":"1477046"},"PeriodicalIF":0.0,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145806645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}